Biopharma firm MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded to Peer Perform from Outperform at Wolfe Research, citing concerns on overpromised timelines. MLTX down about 2% premarket. “Lacking…
Browsing: downgraded
Healthcare companies supplier Premier Inc (NASDAQ:PINC) was downgraded to Hold from Buy at Benchmark on Monday after the corporate guided its FY25-26 outlook under Street estimates.…
Biopharma firm MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded to Peer Perform from Outperform at Wolfe Research, citing concerns on overpromised timelines. MLTX down about 2% premarket. “Lacking…
Healthcare companies supplier Premier Inc (NASDAQ:PINC) was downgraded to Hold from Buy at Benchmark on Monday after the corporate guided its FY25-26 outlook beneath Street estimates.…
Biopharma firm MoonLake Immunotherapeutics (NASDAQ:MLTX) was downgraded to Peer Perform from Outperform at Wolfe Research, citing concerns on overpromised timelines. MLTX down about 2% premarket. “Lacking…